JNJ

Johnson & Johnson · Healthcare · Drug Manufacturers - General
$253.85
-3.92 (-1.52%)
Mkt Cap: 611.07B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield3.9%
Dividend YieldN/A
Market Cap611.07B
Volume8.77M
Recent News
Johnson & Johnson Hikes Guidance, Stock Falls
barrons.com · 2026-07-15
Johnson & Johnson Bumps Up Guidance as Sales Rise
wsj.com · 2026-07-15
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026
businesswire.com · 2026-07-15
J&J quarterly earnings beat Wall Street estimates on strength of medicines unit
reuters.com · 2026-07-15
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
businesswire.com · 2026-07-15
Morgan Stanley, Johnson & Johnson And 3 Stocks To Watch Heading Into Wednesday
benzinga.com · 2026-07-15

Unlock the Full Deep Scan

9 AI agents analyze JNJ across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →